The First Human Clinical Trial on the Skin Depigmentation Efficacy of Glycinamide Hydrochloride
A previous study identified certain low molecular anti-melanogenic peptides that share a common sequence with α-melanocyte stimulating hormone (MSH) and end with a glycinamide moiety. Glycinamide itself also showed anti-melanogenic activity in cell-based assays, but neither glycine nor acetyl glycin...
Main Authors: | Yong Chool Boo, Da Jung Jo, Chang Min Oh, Shin Young Lee, Young Mi Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/8/8/257 |
Similar Items
-
Human Skin Lightening Efficacy of Resveratrol and Its Analogs: From in Vitro Studies to Cosmetic Applications
by: Yong Chool Boo
Published: (2019-08-01) -
Arbutin as a Skin Depigmenting Agent with Antimelanogenic and Antioxidant Properties
by: Yong Chool Boo
Published: (2021-07-01) -
Spreading of Dangerous Skin-Lightening Products as a Result of Colourism: A Review
by: Claudia C. A. Juliano
Published: (2022-03-01) -
Combination of Glycinamide and Ascorbic Acid Synergistically Promotes Collagen Production and Wound Healing in Human Dermal Fibroblasts
by: Ji Eun Lee, et al.
Published: (2022-04-01) -
Stereoselective Synthesis of β-Glycinamide Ribonucleotide
by: Lisa Ngu, et al.
Published: (2022-04-01)